Medical Technology News

Diabetic Retinopathy Market Size Worth USD4,490 Mn by 2027

Press release   •   Sep 20, 2019 12:59 EDT

Global Diabetic Retinopathy Market size is expected to reach $4,490 million by 2027, supported by a CAGR of 21.4% during the forecast period 2019 to 2027. Increasing prevalence of diabetes along with growing incidence of blindness due to diabetes is anticipated to propel the market growth over the forecast period.

The list of key players profiled in this report include Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals., Bayer AG, F. Hoffmann-La Roche, Novartis International AG, Pfizer, Regeneron Pharmaceuticals Inc., and Valeant Pharmaceutical.

Key players in the value chain include Boehringer Ingelheim GmbH, KOWA Company, Ltd., BCN Peptides S.A., and ThromboGenics NV.

Get Free Sample Pages Fore More Understanding@

The main objective of this report is to define, describe, and forecast the global diabetic retinopathy market on the basis of types of applications, major sectors, deployment models, organization size, and regions. This report mainly introduces volume and value market share by segments and also their price change details. The analysis includes the market by value, by segments, by application, by manufacturers and by region. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2019 to 2027. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2019 to 2027, considering 2018 as the base year. All market data presented in revenues, shipments and installed base, along with average pricing data.

The report contains an analysis of the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges). It aims to strategically analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the market. The report also offers insightful and detailed information regarding the various key players operating in the global market, and their financials, apart from strategies, acquisitions & mergers, and market footprint.

The report forecasts the market size, in terms of value, for various segments with regard to four main regions—North America, Europe, APAC, and RoW. It strategically profiles key players and comprehensively analyzes their market rankings and core competencies, along with detailing the competitive landscape for the market leaders.

The report also tracks and analyzes competitive developments, including partnerships, collaborations, acquisitions, new product developments, and R&D activities in the market. The report analyze detailed profiles of 20+ innovative and leading vendors, with information on products and services, target markets, strategy, SWOT analysis, key relationships and capital funding.

The research methodology used to estimate and forecast the market begins with capturing data on key vendor’s revenues through secondary research. The vendor offerings are also taken into consideration to determine the market segmentation. The bottom-up procedure was employed to arrive at the overall market size of the global market from the revenue of the key players in the market. After arriving at the overall market size, the total market was split into several segments and sub-segments, which were then verified through primary research by conducting extensive interviews with key people, such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures were employed to complete the overall market engineering process and to arrive at the exact statistics for all segments and sub-segments.

Request to Buy This Report From@

Key Benefits

-This report provides an extensive analysis of the current and emerging market trends and dynamics in the global diabetic retinopathy market.
-Comprehensive analysis of geographical regions is provided to determine the prevailing opportunities in the market.
-This study provides the competitive landscape of the market to predict the competitive environment across geographies.
-This report entails the detailed quantitative analysis of the current market and estimations from 2014 to 2022 to identify the prevailing opportunities.
-Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
-Region- and country-wise diabetic retinopathy market conditions are comprehensively analyzed in the report to understand the regional trends and dynamics.

Diabetic Retinopathy Market Key Segments

By Type

Proliferative Diabetic Retinopathy
Diabetic Macular Edema (DME)

By Treatment Type
Anti VEGF Drug
Steroid Implants
Laser Surgeries

By Region
North America
Rest of Europe
South Korea
Rest of Asia-Pacific
South Africa
Saudi Arabia
Rest of LAMEA

Request to Buy This Report From@